Cross-border investment and financing projects event

Cross-border investment and financing projects event

Wednesday on the 3rd of May, ARC will host a cross-border investment and financing projects event.

We all must have heard about Cross- Border Investment and how is it essential in the emerging markets, but the first question that pops into our head is what is a cross-border investment?

And how is it different from any other Investment? We will identify the demand for companies which would like to take advantage of overseas capital markets, introduce some practical approaches in financing for small-middle sized companies.

Venue: 1818 6F Fanhai City Plaza, Jianghan District, Wuhan, China Date: Wednesday May 3rd 2017 Time: 13:30h

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission